Clinical Presentation,Diagnosis,and Radiological Findings of Neoplastic Meningitis

Lombardi G. , Zustovich F. , Farina P. Neoplastic meningitis from solid tumors: new diagnostic and therapeutic approaches. Oncologist. 2011; 16(8): 1175–1188.

Pauls S. , Fischer A.C. , Brambs H.J. Use of magnetic resonance imaging to detect neoplastic meningitis: limited use in leukemia and lymphoma but convincing results in solid tumors. Eur J Radiol. 2012; 81(5): 974–978.

Martins S.J. , Azevedo C.R. , Chinen L.T. Meningeal carcinomatosis in solid tumors. Arq Neuropsiquiatr. 2011; 69(6): 973–980.

Chamberlain M.C. Leptomeningeal metastasis. Curr Opin Neurol. 2009; 22(6): 665–674.

Chamberlain M.C. Neoplastic meningitis. Oncologist. 2008; 13(9): 967–977.

Leal T. , Chang J.E. , Mehta M. Leptomeningeal metastasis: challenges in diagnosis and treatment. Curr Cancer Ther Rev. 2011; 7(4): 319–327.

Chamberlain M.C. Neoplastic meningitis. Curr Neurol Neurosci Rep. 2008; 8(3): 249–258.

Clarke J.L. Leptomeningeal metastasis from systemic cancer. Continuum (Minneap Minn). 2012; 18(2): 328–342.

Sabater A.L. , Sadaba L.M. , de Nova E. Ocular symptoms secondary to meningeal carcinomatosis in a patient with lung adenocarcinoma: a case report. BMC Opthalmol. 2012; 12: 65.

Clarke J.L. , Perez H.R. , Jacks L.M. Leptomeningeal metastases in the MRI era. Neurology. 2010; 74(18): 1449–1454.

Wasserstrom W.R. , Glass J.P. , Posner J.B. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer. 1982; 49(4): 759–772.

Chamberlain M.C. Comparative spine imaging in leptomeningeal metastases. J Neurooncol. 1995; 23(3): 233–238.

Drappatz J. , Batchelor T.T. Leptomeningeal and peripheral nerve metastases. Continuum (Minneap Minn). 2005; 11(5): 47–68.

Waki F. , Ando M. , Takashima A. Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors. J Neurooncol. 2009; 93(2): 205–212.

Choi E. , Lewis A.L. , Takei H. Leptomeningeal carcinomatosis as initial presentation in adenocarcinoma of lung with signet ring cell features: an autopsy case report. Int J Clin Exp Pathol. 2012; 5(9): 972–976.

Lara-Medina F. , Crismatt A. , Villarreal-Garza C. Clinical features and prognostic factors in patients with carcinomatous meningitis secondary to breast cancer. Breast J. 2012; 18(3): 233–241.

Sim K.B. , Nam K.Y. , Lee H.J. Chest wall pain as the presenting symptom of leptomeningeal carcinomatosis. Ann Rehabil Med. 2014; 38(6): 861–864.

Guo J.W. , Zhang X.T. , Chen X.S. Leptomeningeal carcinomatosis as the initial manifestation of gastric adenocarcinoma: a case report. World J Gastroenterol. 2014; 20(8): 2120–2126.

Scott B.J. , Kesari S. Leptomeningeal metastases in breast cancer. Am J Cancer Res. 2013; 3(2): 117–126.

Lee S.J. , Lee J.I. , Nam D.H. Leptomeningeal carcinomatosis in non-small-cell lung cancer patients. J Thorac Oncol. 2013; 8(2): 185–191.

Grisold W. , Grisold A. Cancer around the brain. Neurooncol Pract. 2014; 1(1) 13–21.

Casciato D.A. , Territo M.C. , eds. Manual of Clinical Oncology. 7th ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2012.

Connolly K.J. , Hammer S.M. The acute aseptic meningitis syndrome. Infect Dis Clin North Am. 1990; 4(4): 599–622.

Shalabi M. , Whitley R.J. Recurrent benign lymphocytic meningitis. Clin Infect Dis. 2006; 43(9): 1194–1197.

Crossley G.H. , Dismukes W.E. Central nervous system epider-moid cyst: a probable etiology of Mollaret's meningitis. Am J Med. 1990; 89(6): 805–806.

Calabrese L.H. , Furlan A.J. , Gragg L.A. Primary angiitis of the central nervous system: diagnostic criteria and clinical approach. Cleve Clin J Med. 1992; 59(3): 293–306.

Francolini M. , Sicurella L. , Rizzuto N. Leptomeningeal carcinomatosis mimicking Creutzfeldt-Jakob disease: clinical features, laboratory tests, MRI images, EEG findings in an autopsy-proven case. Neurol Sci. 2013; 34(4): 441–444.

Jolles S. , Sewell W.A. , Leighton C. Drug-induced aseptic meningitis: diagnosis and management. Drug Saf. 2000; 22(3): 215–226.

Escalante A. , Stimmler M.M. Trimethoprim-sulfamethoxazole induced meningitis in systemic lupus erythematosus. J Rheumatol. 1992; 19(5): 800–802.

Feinstein T.M. , Gibson M.K. , Argiris A. Cetuximab-induced aseptic meningitis. Ann Oncol. 2009; 20(9): 1609–1610.

Maniyar F. , Rooney C. , Lily O. Anticonvulsant hypersensitivity syndrome presenting as aseptic meningitis. J Neurol. 2009; 256(7): 1190–1191.

Glantz M.J. , Cole B.F. , Glantz L.K. Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results. Cancer. 1998; 82(4): 733–739.

DeAngelis L.M. Current diagnosis and treatment of leptomeningeal metastasis. J Neurooncol. 1998; 38(2-3): 245–252.

Kaplan J.G. , DeSouza T.G. , Farkash A. Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias. J Neurooncol. 1990; 9(3): 225–229.

Spanos A. , Harrell F.E. Jr , Durack D.T. Differential diagnosis of acute meningitis. An analysis of the predictive value of initial observations. JAMA. 1989; 262(19): 2700–2707.

Illán J. , Simo M. , Serrano C. Differences in cerebrospinal fluid inflammatory cell reaction of patients with leptomeningeal involvement by lymphoma and carcinoma. Transl Res. 2014; 164(6): 460–467.

Rice S.K. , Heinl R.E. , Thornton L.L. Clinical characteristics, management strategies, and cost implications of a statewide outbreak of enterovirus meningitis. Clin Infect Dis. 1995; 20(4): 931–937.

Hauke R.J. , Tarantolo S.R. , Bashir R.M. Central nervous system Hodgkin's disease relapsing with eosinophilic pleocytosis. Leuk Lymphoma. 1996; 21(1-2): 173–175.

van de Beek D. , de Gans J. , Spanjaard L. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004; 351(18): 1849–1859.

Litvintseva A.P. , Lindsley M.D. , Gade L. Utility of (1-3)-β-D-glucan testing for diagnostics and monitoring response to treatment during the multistate outbreak of fungal meningitis and other infections. Clin Infect Dis. 2014; 58(5): 622–630.

Kupila L. , Vuorinen T. , Vainionpää R. Etiology of aseptic meningitis and encephalitis in an adult population. Neurology. 2006; 66(1): 75–80.

Huy N.T. , Thao N.T. , Diep D.T. Cerebrospinal fluid lactate concentration to distinguish bacterial from aseptic meningitis: a systemic review and meta-analysis. Crit Care. 2010; 14(6): R240.

Sakushima K. , Hayashino Y. , Kawaguchi T. Diagnostic accuracy of cerebrospinal fluid lactate for differentiating bacterial meningitis from aseptic meningitis: a meta-analysis. J Infect. 2011; 62(4): 255–262.

Dash P.C. , Patro D. Role of CSF CK, LDH, GGTP enzyme levels in diagnostic and prognostic evaluation of meningitis. J Clin Diagn Res. 2014; 8(7): MC19–MC22.

Lossos A. , Siegal T. Spinal subarachnoid hemorrhage associated with leptomeningeal metastases. J Neurooncol. 1992; 12(2): 167–171.

Mehling M. , Kuhle J. , Regeniter A. 10 most commonly asked questions about cerebrospinal fluid characteristics in demyelinating disorders of the central nervous system. Neurologist. 2008; 14(1): 60–65.

Cheng T.M. , O'Neill B.P. , Scheithauer B.W. Chronic meningitis: the role of meningeal or cortical biopsy. Neurosurgery. 1994; 34(4): 590–595.

Smith J.E. , Aksamit A.J. Outcome of chronic idiopathic meningitis. Mayo Clin Proc. 1994; 69(6): 548–556.

Gorson K.C. , Ropper A.H. , Muriello M.A. Prospective evaluation of MRI lumbosacral nerve root enhancement in acute Guillain-Barré syndrome. Neurology. 1996; 47(3): 813–817.

Smirniotopoulos J.G. , Murphy F.M. , Rushing E.J. Patterns of contrast enhancement in the brain and meninges. Radiographics. 2007; 27(2): 525–551.

Mittl R.L. Jr , Yousem D.M. Frequency of unexplained meningeal enhancement in the brain after lumbar puncture. AJNR Am J Neuroradiol. 1994; 15(4): 633–638.

Chamberlain M. , Soffietti R. , Raizer J. Leptomeningeal metastasis: a response assessment in neuro-oncology critical review of endpoints and response criteria of published randomized clinical trials. Neuro Oncol. 2014; 16(9): 1176–1185.

Khil E.K. , Lee A.L. , Chang K.H. Symmetrical curvilinear cytotoxic edema along the surface of the brain stem: a probable new magnetic resonance imaging finding of leptomeningeal carcinomatosis. Medicine (Baltimore). 2015; 94(29): e1053.

Confavreux C.B. , Cotton F. , Tebib J.G. Advanced MRI could help to differentiate meningeal carcinomatosis with mass effect from cerebral metastasis in prostate cancer. Bull Cancer. 2006; 93(4): E31–E35.

Cho H.R. , Wen H. , Ryu Y.J. An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis. Cancer Res. 2012; 72(20): 5179–5187.

An Y.J. , Cho H.R. , Kim T.M. An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients. Int J Cancer. 2015; 136(1): 162–171.

Marini A. , Carulli G. , Lari T. Myelomatous meningitis evaluated by multiparameter flow cytometry: report of a case and review of the literature. J Clin Exp Hematop. 2014; 54(2): 129–136.

Renard D. , Dufour S. , Collombier L. Cerebral FDG-PET hyper-metabolism in carcinomatous meningitis. Eur Neurol. 2011; 66(6): 332–333.

Komori T. , Delbeke D. Leptomeningeal carcinomatosis and intramedullary spinal cord metastases from lung cancer: detection with FDG positron emission tomography. Clin Nucl Med. 2001; 26(11): 905–907.

Shah S. , Rangarajan V. , Purandare N. 18F-FDG uptakes in leptomeningeal metastases from carcinoma of the breast on a positron emission tomography/computerized tomography study. Indian J Cancer. 2007; 44(3): 115–118.

Padma M.V. , Jacobs M. , Kraus G. 11C-methionine PET imaging of leptomeningeal metastases from primary breast cancer– a case report. J Neurooncol. 2001; 55(1): 39–44.

Kim L. , Glantz M.J. Neoplastic meningitis. Curr Treat Options Oncol. 2001; 2(6): 517–527.

Strik H. , Prommel P. Diagnosis and individualized therapy of neoplastic meningitis. Expert Rev Anticancer Ther. 2010; 10(7): 1137–1148.

Bruna J. , Simó M. , Velasco R. Leptomeningeal metastases. Curr Treat Options Neurol. 2012; 14(4): 402–415.

Chamberlain M.C. Leptomeningeal metastasis. Curr Opin Oncol. 2010; 22(6): 627–635.

Straus S.E. , Thorpe K.E. , Holroyd-Leduc J. How do I perform a lumbar puncture and analyze the results to diagnose bacterial meningitis. JAMA. 2006; 296(16): 2012–2022.

Chamberlain M.C. , Kormanik P.A. , Glantz M.J. A comparison between ventricular and lumbar cerebrospinal fluid cytology in adult patients with leptomeningeal metastases. Neuro Oncol. 2001; 3(1): 42–45.

Le Rhun E. , Taillibert S. , Chamberlain M.C. Carcinomatous meningitis: Leptomeningeal metastases in solid tumors. Surg Neurol Int. 2013; 4(suppl 4): S265–S288.

Weller P.F. , Liu L.X. Eosinophilic meningitis. Semin Neurol. 1993; 13(2): 161–168.

Walker J.G. Diagnosis and management of leptomeningeal disease. Clin J Oncol Nurs. 2009; 13(4): 384–387.

Rogers L.R. , Duchesneau P.M. , Nunez C. Comparison of cister-nal and lumbar CSF examination in leptomeningeal metastasis. Neurology. 1992; 42(6): 1239–1241.

van Zanten A.P. , Twijnstra A. , Hart A.A. Cerebrospinal fluid lactate dehydrogenase activities in patients with central nervous system metastases. Clin Chim Acta. 1986; 161(3): 259–268.

Fleisher M. , Wasserstrom W.R. , Schold S.C. Lactic dehydrogenase isoenzymes in the cerebrospinal fluid of patients with systemic cancer. Cancer. 1981; 47(11): 2654–2659.

Almeida S.M. , Cunha D.S. , Yamada E. Quantification of cerebrospinal fluid ferritin as a biomarker for CNS malignant infiltration. Arq Neuropsiquiatr. 2008; 66(3B): 720–724.

Hoshino T. , Kumasaka K. , Kawano K. Abnormal alkaline phos-phatase of hepatic type in cerebrospinal fluid of a patient with intracranial metastasis from lung cancer. J Clin Pathol. 1993; 46(11): 1059–1061.

Nakagawa H. , Kubo S. , Murasawa A. Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis and brain tumors. J Neurooncol. 1992; 12(2): 111–120.

Klee G.G. , Tallman R.D. , Goellner J.R. Elevation of carcinoembryonic antigen in cerebrospinal fluid among patients with meningeal carcinomatosis. Mayo Clin Proc. 1986; 61(1): 9–13.

Rombos A. , Evangelopoulu-Katsiri E. , Mariatos P. Cerebrospinal fluid carcinoembryonic antigen and alphafetoprotein in patients with central nervous system neoplasia. Acta Neurol Scand. 1988; 77(6): 440–444.

Ongerboer de Visser B.W. , van Zanten A.P. , Twijnstra A. Sensitivity and specificity of cerebrospinal fluid biochemical markers of central nervous system metastases. Prog Exp Tumor Res. 1985; 29: 105–115.

Pudek M.R. , Chan K.W. , Rogers P.C. Beta 2-microglobulin levels in cerebrospinal fluid of children with leukemia and lymphoma. Clin Biochem. 1985; 18(3): 180–183.

Bernstein W.B. , Kemp J.D. , Kim G.S. Diagnosing leptomeningeal carcinomatosis with negative CSF cytology in advanced prostate cancer. J Clin Oncol. 2008; 26(19): 3281–3284.

Cante D. , Franco P. , Sciacero P. Leptomeningeal metastasis from prostate cancer. Tumori. 2013; 99(1): 6e–10e.

Moseley R.P. , Oge K. , Shafqat S. HMFG1 antigen: a new marker for carcinomatous meningitis. Int J Cancer. 1989; 44(3): 440–444.

Sölétormos G. , Bach F. Cerebrospinal fluid cytokeratins for diagnosis of patients with central nervous system metastases from breast cancer. Clin Chem. 2001; 47(5): 948–950.

Bruno M.K. , Raizer J. Leptomeningeal metastases from solid tumors (meningeal carcinomatosis). Cancer Treat Res. 2005; 125: 31–52.

Corsini E. , Bernardi G. , Gaviani P. Intrathecal synthesis of tumor markers is a highly sensitive test in the diagnosis of leptomeningeal metastasis from solid cancers. Clin Chem Lab Med. 2009; 47(7): 874–879.

Weller M. , Sommer N. , Stevens A. Increased intrathecal synthesis of fibronectin in bacterial and carcinomatous meningitis. Acta Neurol Scand. 1990; 82(2): 138–142.

Siegal T. , Ovadia H. , Yatsiv I. CSF myelin basic protein levels in leptomeningeal metastases. Relationship to disease activity. J Neurol Sci. 1987; 78(2): 165–173.

Kanaji N. , Bandoh S. , Nagamura N. Significance of an epidermal growth factor receptor mutation in cerebrospinal fluid for carcinomatous meningitis. Intern Med. 2007; 46(19): 1651–1655.

Kuusisto M.E. , Haapasaari K.M. , Remes A.M. Antithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma. Ann Hematol. 2015l; 94(7): 1167–1174.

Herrlinger U. , Wiendl H. , Renninger M. Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic value. Br J Cancer. 2004; 91(2): 219–224.

Groves M.D. , Hess K.R. , Puduvalli V.K. Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma. J Neurooncol. 2009; 94(2): 229–234.

Bach F. , Bach F.W. , Pedersen A.G. Creatine kinase-BB in the cerebrospinal fluid as a marker of CNS metastases and leptomeningeal carcinomatosis in patients with breast cancer. Eur J Cancer Clin Oncol. 1989; 25(12): 1703–1709.

Priola G.M. , Foster M.W. , Deal A.M. Cerebrospinal fluid proteomics in children during induction for acute lymphoblastic leukemia: a pilot study. Pediatr Blood Cancer. 2015; 62(7): 1190–1194.

Nakamizo S. , Sasayama T. , Shinohara M. GC/MS-based metabolomic analysis of cerebrospinal fluid (CSF) from glioma patients. J Neurooncol. 2013; 113(1): 65–74.

Nowakowski G.S. , Call T.G. , Morice W.G. Clinical significance of monoclonal B cells in cerebrospinal fluid. Cytometry B Clin Cytom. 2005; 63(1): 23–27.

Trojanowski J.Q. , Atkinson B. , Lee V.M. An immunocytochemical study of normal and abnormal human cerebrospinal fluid with monoclonal antibodies to glial fibrillary acidic protein. Acta Cytol. 1986; 30(3): 235–239.

Pittman M. , Treese S. , Chen L. Utility of flow cytometry of cerebrospinal fluid as a screening tool in the diagnosis of central nervous system lymphoma. Arch Pathol Lab Med. 2013; 137(11): 1610–1618.

Scott B.J. , Douglas V.C. , Tihan T. A systematic approach to the diagnosis of suspected central nervous system lymphoma. JAMA Neurol. 2013; 70(3): 311–319.

Ahluwalia M.S. , Wallace P.K. , Peereboom D.M. Flow cytometry as a diagnostic tool in lymphomatous or leukemic meningitis: ready for prime time? Cancer. 2012; 118(7): 1747–1753.

Subirá D. , Simó M. , Illán J. Diagnostic and prognostic significance of flow cytometry immunophenotyping in patients with leptomeningeal carcinomatosis. Clin Exp Metastasis. 2015; 32(4): 383–391.

Milojkovic Kerklaan B. , Pluim D. , Bol M. EpCAM-based flow cytometry in cerebrospinal fluid greatly improves diagnostic accuracy of leptomeningeal metastases from epithelial tumors. Neuro Oncol. 2016; 18(6): 855–862.

Strik H. , Luthe H. , Nagel I. Automated cerebrospinal fluid cytology: limitations and reasonable applications. Anal Quant Cytol Histol. 2005; 27(3): 167–173.

Heller T. , Nagel I. , Ehrlich B. Automated cerebrospinal fluid cytology. Anal Quant Cytol Histol. 2008; 30(3): 139–144.

Weston C.L. , Glantz M.J. , Connor J.R. Detection of cancer cells in the cerebrospinal fluid: current methods and future directions. Fluids Barriers CNS. 2011; 8(1): 14.

van Oostenbrugge R.J. , Hopman A.H. , Arends J.W. Treatment of leptomeningeal metastases evaluated by interphase cytogenetics. J Clin Oncol. 2000; 18(10): 2053–2058.

van Oostenbrugge R.J. , Hopman A.H. , Lenders M.H. Detection of malignant cells in cerebrospinal fluid using fluorescence in situ hybridization. J Neuropathol Exp Neurol. 1997; 56: 743–748.

Lin X. , Fleisher M. , Shagabayeva L. Detection of cerebral spinal fluid (CSF) circulating melanoma cells (CMC) for the diagnosis of melanoma leptomeningeal metastasis (LM). J Clin Oncol. 2015: e13061.

Tu Q. , Wu X. , Le Rhun E. CellSearch technology applied to the detection and quantification of tumor cells in CSF of patients with lung cancer leptomeningeal metastasis. Lung Cancer. 2015; 90(2): 352–357.

Lin X. , Fleisher M. , Shagabayeva L. Prospective validation of cerebrospinal fluid (CSF) circulating tumor cells (CTC) to diagnose leptomeningeal metastasis (LM) from epithelial tumors. J Clin Oncol. 2015; 33(15 suppl): e13061.

Pan W. , Gu W. , Nagpal S. Brain tumor mutations detected in cerebral spinal fluid. Clin Chem. 2015; 61(3): 514–522.

Wang Y. , Springer S. , Zhang M. Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord. Proc Natl Acad Sci U S A. 2015; 112(31): 9704–9709.

Vinayanuwattikun C. , Mingmalairak S. , Jittapiromsak N. SHP-1 promoter 2 methylation in cerebrospinal fluid for diagnosis of leptomeningeal epithelial-derived malignancy (carcinomatous meningitis). J Neurooncol. 2016; 129(3): 395–403.